Viralytics is about to become a subsidiary of Merck
there is almost no way this isn't going to happen Imo
too much success has gone on with the combo trials too much business history
even if this share had been trading at $1 its beyond doubtful premium would have been over 75c anyway - that is huge as it is
crazy to set yourself up for disappointment ...time to find a new baby
H1 2018 Results (Pending), page-2
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
